BUENA, N.J.--(BUSINESS WIRE)--IGI LABORATORIES, INC. (AMEX:IG) a premier global provider of skin treatment products will begin manufacturing and packaging commercial prescription products for another new pharmaceutical customer. The two prescription products are indicated for the management of symptoms associated with several dermal conditions.
